TLR4 and RAGE: Similar routes leading to inflammation in type 2 diabetic patients

Diabetes and Metabolism

Volumn 37, Issue 4, 2011, Pages 336-342

  Veloso, C A ^a   Fernandes, J S ^a   Volpe, C M O ^a   Fagundes Netto, F S ^a   Reis, J S ^a   Chaves, M M ^b   Nogueira Machado, J A ^a  

^a Hospital Santa Casa de Belo Horizonte   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

IL 6; Peripheral blood mononuclear cells; Proinflammatory cytokines; RAGE; TLR4; TNF ; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053130779     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.12.005     Document Type: Article

References (49)

1. Nogueira-Machado J.A., Chaves M.M. From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous route for diabetic patients. Expert Opin Ther Targets 2008, 12:1-12.
2. Pickup J.C., Mattock M.B., Chusney G.D., Burt T. NIDDM as a disease of the innate immune system: association of acute phase reactants and inteleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286-1292.
3. Pickup J.C., Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41:1241-1248.
4. Tschop M., Thomas G. Fat fuels insulin resistance through Toll-like receptors. Nat Med 2006, 12:1359-1361.
5. Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003, 44:479-486.
6. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
7. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11:1173-1179.
8. Lundberg A.M., Drexler S.K., Monaco C., Williams L.M., Sacre S.M., Feldmann M., et al. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 2007, 110:3245-3252.
9. Lee M.S., Kim Y.J. Signaling pathways downstream of pattern-recognition receptors and their cross-talk. Annu Rev Biochem 2007, 76:447-480.
10. Qi H.Y., Shelhamer J.H. Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J Biol Chem 2005, 280:38969-38975.
11. Yang C.S., Shin D.M., Lee H.M., Son J.W., Lee S.J., Akira S., et al. ASK-1 p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signaling. Cell Microbiol 2008, 10:741-754.
12. Zarember K.A., Godowski P.J. Tissue expression of human toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002, 168:554-561.
13. Girling J.E., Hedger M.P. Toll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology. Immunol Cell Biol 2007, 85:481-489.
14. Lin L. RAGE on the toll road?. Cell Mol Immunol 2006, 3:351-358.
15. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994, 269:9889-9897.
16. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Du Yan S., et al. Ne{open}-(carboximethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 1999, 31740-31749.
17. Bierhaus A., Hofmann M.A., Ziegler R., Nawroth P.P. AGEs and their interactions with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998, 37:586-600.
18. Berg T.J., Claussen J.T., Torjesen P.A., Dahl-Jorgensen K., Bangstad H.J., Hanssen K.F. The advanced glycation end product Ne{open}-(carboximethyl)lysine is increased in serum from children and adolescents with type 1 diabetes. Diabetes care 1998, 21:1997-2002.
19. Tan K.C., Chow W.S., Tam S., Bucala R., Betteridge J. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care 2004, 27:223-228.
20. Bicalho H.M., Gontijo C.M., Nogueira-Machado J.A. A simple technique for simultaneous human leukocyte separation. J Immunol Methods 1981, 40:115-116.
21. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1:398-401.
22. Rassa J.C., Meyers J.L., Zhang Y., Kudavalli R., Ross S.R., et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A 2002, 99:2281-2286.
23. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001, 13:85-94.
24. Tsan M.F., Ghao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004, 76:514-519.
25. Tobias P.S., Curties L.K. Toll-like receptors in atherosclerosis. Biochem Soc Trans 2007, 35:1453-1455.
26. Devaraj S., Dasu M.R., Rockwood J., Winter W., Griffen S.C., Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008, 93:578-583.
27. Devaraj S., Dasu M.R., Park S.H., Jialal I. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 2009, 52:1665-1668.
28. Dasu M.R., Devaraj S., Park S., Jialal I. Increased Toll-Like Receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010, 33:861-868.
29. Buraczynska M., Baranowicz-Gaszczyk I., Tarach J., Ksiazek A. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum Immunol 2009, 70:121-124.
30. Ghanin H., Mohanty P., Deopurkar R., Sia C.L., Korzeniewski K., et al. Acute modulation of toll-like receptors by insulin. Diabetes Care 2008, 31:1827-1831.
31. Dasu M.R., Devaraj S., Zhao L., Hwang D.H., Jialal I. High glucose induces Toll-like receptor expression in human monocytes. Diabetes 2008, 57:3090-3098.
32. Triantafilou K., Triantafilou M., Dedrick R.L. A CD14-independent LPS receptor cluster. Nat Immunol 2001, 2:338-345.
33. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25:187-191.
34. Lander H.M., Tauras J.M., Ogiste J.S., Hori O., Moss A.S., et al. Activation of the receptor fro advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997, 272:17810-17814.
35. Huttunen H.F., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappa-B require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999, 274:19919-19924.
36. Sakaguchi T., Yan S.F., Yan S.D., Belov D., Rong L.L., et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003, 111:959-972.
37. van Beijnum J.R., Buurman W.A. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group box 1 (HMGB1). Angiogenesis 2008, 11:91-99.
38. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev 2005, 5:331-342.
39. Ghanin H., Abuaysheh S., Sia C.L., Korzeniewski K., Chaudhuri A., et al. Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal. Diabetes Care 2009, 32:2281-2287.
40. Deopurkar R., Ghanin H., Friedman J., Abuaysheh S., Sia C.L., et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 2010, 33:991-997.
41. Tripathy D., Mohanty P., Dhindsa S., Syed T., Ghanin H., et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003, 52:2882-2887.
42. Ghanim H., Aljada A., Hofmeyer D., Syed T., Mohanty P., et al. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004, 110:1564-1571.
43. Goodwin G.H., Johns E.W. Are the high mobility group non-histone chromosomal proteins associated with 'active' chromatin?. Biochim Biophys Acta 1978, 519:279-284.
44. Zhang S., Zhong J., Yang P., Gong F., Wang C.Y. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol 2010, 3:24-38.
45. West K.L., Castellini M.A., Duncan M.K., Bustin M. Chromosomal proteins HMBN3a and HMBN3b regulate the expression of glycine transporter 1. Mol Cell Biol 2004, 24:3747-3756.
46. Stros M., Ozaki T., Bacikova A., Kageyama H., Nakagawara A. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequencespecific transactivation from the human Bax gene promoter. J Biol Chem 2002, 277:7157-7164.
47. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003, 284:C917-C924.
48. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A., et al. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group Box 1 protein. J Biol Chem 2004, 279:7370-7377.
49. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003, 22:5551-5560.